Discovery of 1-{(3<i>R</i>,4<i>R</i>)-3-[({5-Chloro-2-[(1-methyl-1<i>H</i>-pyrazol-4-yl)amino]-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR MutantsHengmiao Cheng, Ru Zhou, Martin P. Edwards et al.|Journal of Medicinal Chemistry|2016Cited by 93
Structure-Based Drug Design and Synthesis of PI3Kα-Selective Inhibitor (PF-06843195)Hengmiao Cheng, John C. Kath, Suvi T. M. Orr et al.|Journal of Medicinal Chemistry|2020Cited by 40
Design and Synthesis of Functionally Active 5-Amino-6-Aryl Pyrrolopyrimidine Inhibitors of Hematopoietic Progenitor Kinase 1Rebecca A. Gallego, Sajiv K. Nair, Louise Bernier et al.|Journal of Medicinal Chemistry|2023Cited by 37
Discovery of PF-07265028, A Selective Small Molecule Inhibitor of Hematopoietic Progenitor Kinase 1 (HPK1) for the Treatment of CancerRebecca A. Gallego, Sajiv K. Nair, Sujin Cho-Schultz et al.|Journal of Medicinal Chemistry|2024Cited by 19
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 InhibitorGary M. Gallego, Sajiv K. Nair, Cynthia L. Palmer et al.|Journal of Medicinal Chemistry|2025Cited by 4